Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor

Alexey E Granovsky1, Marsha Rich Rosner

  • 1Ben May Department for Cancer Research, University of Chicago, 929 East 57th Street, Chicago, IL 60637, USA.

Cell Research
|April 2, 2008
PubMed

Insights

Raf Kinase Inhibitory Protein (RKIP) maintains cellular balance by regulating key signaling pathways. Loss of RKIP disrupts cell stability, potentially leading to cancer and other diseases.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cells possess intricate regulatory mechanisms to preserve integrity and prevent aberrant state transitions.
  • Raf Kinase Inhibitory Protein (RKIP), a member of the phosphatidylethanolamine binding protein (PEBP) family, modulates critical signaling cascades.
  • RKIP plays a role in maintaining biological system balance, often referred to as "yin yang" homeostasis.

Purpose of the Study:

  • To provide an updated analysis of RKIP.
  • To highlight RKIP's unique characteristics as a regulator of cellular signaling.
  • To emphasize RKIP's role in maintaining cellular stasis and preventing disease.

Main Methods:

  • Review and analysis of existing literature on RKIP and PEBP family.
  • Examination of RKIP's inhibitory functions on specific signaling pathways (MAPK, GPCR kinase, NF-κB).
  • Investigation of RKIP's phosphorylation-dependent targeting of kinases and integration of signaling crosstalk.

Main Results:

  • RKIP inhibits multiple signaling cascades, including Raf-MEK-ERK, GPCR kinase, and NF-κB pathways.
  • RKIP's phosphorylation state dictates its kinase targets, enabling integration of signals from diverse environmental stimuli.
  • Loss or depletion of RKIP is associated with disrupted cellular homeostasis, chromosomal abnormalities, and diseases like cancer.

Conclusions:

  • RKIP is a critical regulator of cellular signaling, maintaining balance and preventing disease.
  • RKIP's ability to target different kinases based on phosphorylation integrates complex cellular responses.
  • Understanding RKIP's unique features is crucial for comprehending cellular regulation and disease pathogenesis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...